Glyphosate, a weed-killing chemical developed by Monsanto in 1970, is the key ingredient in the company’s “Roundup” label of herbicides. In the decades since, Monsanto has created and patented a number of genetically-modified organisms and genetically-engineered crops resisted to glyphosate that are sold worldwide under the company’s “Roundup Ready” brand. Those GMO products are then planted in fields where glyphosate, namely Roundup, is used en masse to eliminate weeds from taking over harvest. With scientists linking that chemical to cancerous diseases, though, critics decry the EPA decision and caution it could do more harm than good.
Through the EPA’s new standards, the amount of allowable glyphosate in oilseed crops such as flax, soybeans and canola will be increased from 20 parts per million (ppm) to 40 ppm, which GM Watch acknowledged is over 100,000 times the amount needed to induce breast cancer cells. Additionally, the EPA is increasing limits on allowable glyphosate in food crops from 200 ppm to 6,000 ppm.
Just last month, The Cornucopia Institute concluded a study by finding glyphosate “exerted proliferative effects in human hormone-dependent breast cancer.” A similar study released in April concluded that “glyphosate enhances the damaging effects of other food borne chemical residues and environmental toxins.”
“Negative impact on the body is insidious and manifests slowly over time as inflammation damages cellular systems throughout the body,” independent scientist Anthony Samsel and MIT’s Stephanie Seneff concluded in the April study. “Consequences are most of the diseases and conditions associated with a Western diet, which include gastrointestinal disorders, obesity, diabetes, heart disease, depression, autism, infertility, cancer and Alzheimer’s disease.” ![]()
